The effect of SGLT2 inhibitor on clinical outcomes in patients with type 2 diabetes and atrial fibrillation | medRxiv

Article usage

Article usage: December 2023 to November 2024

	Abstract	Full	Pdf
Dec 2023	149	5	12
Jan 2024	73	4	5
Feb 2024	35	3	11
Mar 2024	34	2	8
Apr 2024	13	2	8
May 2024	14	4	9
Jun 2024	29	5	3
Jul 2024	28	3	13
Aug 2024	10	1	9
Sep 2024	20	3	7
Oct 2024	10	5	7
Nov 2024	11	1	5

View the discussion thread.

Posted December 21, 2023.

Subject Area

Endocrinology (including Diabetes Mellitus and Metabolic Disease)

Subject Areas

All Articles

Addiction Medicine (390)
Allergy and Immunology (705)
Anesthesia (197)
Cardiovascular Medicine (2880)
Dentistry and Oral Medicine (327)
Dermatology (245)
Emergency Medicine (432)
Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1018)
Epidemiology (12614)
Forensic Medicine (10)
Gastroenterology (811)
Genetic and Genomic Medicine (4480)
Geriatric Medicine (407)
Health Economics (717)
Health Informatics (2868)
Health Policy (1059)
Health Systems and Quality Improvement (1057)
Hematology (378)
HIV/AIDS (909)
Infectious Diseases (except HIV/AIDS) (14026)
Intensive Care and Critical Care Medicine (835)
Medical Education (418)
Medical Ethics (115)
Nephrology (466)
Neurology (4241)
Nursing (228)
Nutrition (621)
Obstetrics and Gynecology (793)
Occupational and Environmental Health (726)
Oncology (2225)
Ophthalmology (632)
Orthopedics (255)
Otolaryngology (322)
Pain Medicine (270)
Palliative Medicine (83)
Pathology (489)
Pediatrics (1182)
Pharmacology and Therapeutics (491)
Primary Care Research (487)
Psychiatry and Clinical Psychology (3695)
Public and Global Health (6827)
Radiology and Imaging (1502)
Rehabilitation Medicine and Physical Therapy (875)
Respiratory Medicine (908)
Rheumatology (430)
Sexual and Reproductive Health (434)
Sports Medicine (374)
Surgery (475)
Toxicology (60)
Transplantation (204)
Urology (175)